Key words: blood pressure-pressor response-heart rate-hippocampus-vasopressin Administration of arginine8-vasopressin (AVP) or prolyl-leucyl-glycinamide (PLG) into a lateral cerebral ventricle reduced the magnitude of systolic blood pressure increase (pressor response) induced by electrical stimulation of the mesencephalic reticular formation (MRF) in urethane-anesthetized rats. Bilateral destruction of the dorsal hippocampus prevented the action of AVP on the pressor response. However, the effect of PLG was only slightly reduced by hippocampal lesion. Microinjection of AVP in the dentate area of the dorsal hippocampus mimicked the action of intracerebroventricularly administered peptides. The effect of a single injection of AVP lasted at least for 60 min. Neither hippocampal damage nor peptide administrations resulted in changes in mean arterial blood pressure (basal BP).
INTRODUCTION
Much data has been collected during the last decade suggesting that the hypothalamic neurosecretory peptide hormone vasopressin (antidiuretic hormone) profoundly influences brain processes related to learning, memory, sleep, drug addiction and tolerance to opiates (for review see refs. 5 and ll). It has also been observed that subcutaneous administration of this peptide facilitates cardiac responses that accompany classical conditioning or passive avoidance behavior in the rat 3,4. The question that was raised by these latter findings is whether the cardiac response changes were correlates of the behavioral actions of vasopressin or were due to a direct peptide effect on brain centers involved in the regulation of the cardiovascular system. In order to investigate this question a model was developed to study cardiovascular responses evoked by the excitation of CNS structures. The posterior hypothalamus or the mesencephalic reticular formation was stimulated electrically with various frequencies or current intensities in urethane-anesthetized rats and the stimulation-induced increase in blood pressure (pressor response) served as the measure of centrally regulated cardiovascular response 2. Lysine8-vasopressin and a fragment of this peptide, desglycinamide9-1ysineS-vasopressin, administered intravenously markedly attenuated the pressor response evoked by posterior hypothalamic stimulation and increased the threshold to evoke a pressor response by the stimulation of the mesen-, cephalic reticular formation 2. Subsequently it was shown that these actions of the peptides are of a central nature. Intracerebroventricular administration of arginineS-vasopressin (AVP) markedly reduced the magnitude of a pressor and bradycardiac response evoked by the stimulation of the mesencephalic reticular formation. This reduction appeared
